Summary of Product Characteristics
last updated on the eMC:
08/11/2007
When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.
Updated on 08/11/2007 and displayed until Current
|
Reasons for adding or updating:
|
-
Change to section 4.6 - Pregnancy and Lactation
-
Change to section 10 date of revision of the text
|
| Date of revision of text on the SPC: 10/2007 |
| Legal Category: P |
| Black Triangle (CHM):
NO |
Free-text change information supplied by the pharmaceutical company
|
The change is as follows:
4.6 Pregnancy and Lactation
The original wording has been replaced with the following:
Pancrex should not be used in pregnancy and lactation unless clearly necessary but if required should be used in doses sufficient to provide adequate nutritional status.
|
|
Updated on 15/03/2006 and displayed until 08/11/2007
|
Reasons for adding or updating:
|
-
Change to section 7 - Marketing Authorisation Holder
-
Change to section 10 (date of (partial) revision of the text
|
|
Updated on 29/09/2004 and displayed until 15/03/2006
|
Reasons for adding or updating:
|
-
Change to section 2 - qualitative and quantitative composition
-
Change to section 4.3 - Contra-indications
-
Change to section 5.1 - Pharmacodynamic Properties
-
Addition of Legal Category
|
|
Updated on 12/07/2002 and displayed until 29/09/2004
|
Reasons for adding or updating:
|
-
Change to section 4.4 - Special Warnings and Precautions for Use
-
Change to section 6.1 - List of Excipients
|
|
Updated on 08/08/2001 and displayed until 12/07/2002
|
Reasons for adding or updating:
|
-
Correction of spelling/typing errors
|
|
Updated on 25/02/2000 and displayed until 08/08/2001
|
Reasons for adding or updating:
|
|
|
|
Updated on 06/09/1999 and displayed until 25/02/2000
|
Reasons for adding or updating:
|
|
|
|